ESR1 and breast carcinoma: Further, on comparing ERα-negative breast cancer cells lines such as MDA-MB 468, HS578T and MDAMD-231 with ERα-positive cell lines such as MCF-7, T47D and MDA-MB 361, there was an expressional difference in miR-221 and miR-222.